Atlas Trials

Clinical Study to Compare Efficacy and Safety of Indinol Forto® 200 mg Capsules and Visanne 2 mg Tablets in Treatment of Endometriosis

Clinical trial NCT07164183 · RECRUITING

Trial details

NCT number
NCT07164183
Sponsor
Alcea
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Endometriosis
Start date
2025-09-11
Primary completion
2026-10-01
Enrollment
290

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.